论文部分内容阅读
目的:观察痰热清注射液治疗毛细支气管炎的临床疗效。方法:将住院治疗的毛细支气管炎患儿120例随机分为两组各60例,对照组给予常规抗感染、吸痰、补液、气道护理等对症治疗,治疗组在对照组基础上加用痰热清注射液0.5 mL/(kg.d)静脉滴注,观察两组患儿的临床症状、体征恢复时间及平均住院时间,并对其疗效进行评价。结果:治疗组总有效率91.67%,对照组总有效率76.67%,两组比较差异有统计学意义(P<0.05)。治疗组的临床症状、体征消失时间及平均住院时间明显短于对照组,两组比较差异均有统计学意义(P<0.01)。结论:痰热清注射液治疗毛细支气管炎能及时控制症状,减轻肺部体征,缩短疗程,且不良反应少,值得临床推广。
Objective: To observe the clinical efficacy of Tanreqing Injection in the treatment of bronchiolitis. Methods: 120 children with bronchiolitis treated in hospital were randomly divided into two groups of 60 cases. The control group was given conventional anti-infective, suctioning, rehydration, airway care and other symptomatic treatment. The treatment group was added on the basis of the control group Tanreqing injection 0.5 mL / (kg.d) intravenous infusion were observed in two groups of children with clinical symptoms, signs of recovery time and the average length of stay, and evaluate its efficacy. Results: The total effective rate was 91.67% in the treatment group and 76.67% in the control group. The difference between the two groups was statistically significant (P <0.05). The clinical symptoms, the disappearance of signs and the average length of hospital stay in the treatment group were significantly shorter than those in the control group, with significant differences between the two groups (P <0.01). Conclusion: Tanreqing injection for the treatment of bronchiolitis can timely control the symptoms, reduce lung signs, shorten the course of treatment, and less adverse reactions, is worth clinical promotion.